Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tourmaline Bio ( (TRML)) has provided an ...

Basel, September 29, 2025 - Novartis today announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer ...

WWE RAW comes to fans live from the Lenovo Center in Raleigh, North Carolina. Here’s how you can watch the show: Where to watch WWE RAW online tonight (September 29) in the U.S. Netflix is the ...

Shares of Tourmaline Oil Corp. TOU shed 0.16% to C$61.89 Thursday, in what proved to be an otherwise all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index ...

WWE RAW comes to fans live from the MassMutual Center in Springfield, Massachusetts. Here’s how you can watch the show: Where to watch WWE RAW online tonight (September 8) in the U.S. Netflix is the ...

Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...

Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...

Novartis agreed to acquire clinical-stage biopharmaceutical maker Tourmaline Bio Inc. in an all-cash deal worth around $1.4 billion.

BERLIN, Sept 9 (Reuters) - Novartis (NOVN.S), opens new tab will acquire Tourmaline Bio (TRML.O), opens new tab for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion ...

Novartis AG agreed to buy Tourmaline Bio Inc. in a deal valued at about $1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to boost its drug pipeline. The company will pay $48 per ...